As you know SYNCROSOME is a Preclinical Drug Evaluation Company specialised in human health.
Since 2000, Syncrosome is mainly focused on in vivo efficacy studies dedicated to discovery and preclinical stage with more than 25 animals models, to provide you the right data to make the right decision.
We offer our services and our expertise in the development of Central Nervous Systeme, Respiratory, Cardiology and Gastroenterology drugs to Big Pharma, Midsize Pharma and Biotechnology Companies...
Syncrosome was selected to present its research on in vivo models to assess compounds in Pulmonary Arterial Hypertension (PAH) field during the P2T congress in Grenoble.
Since a few year now, Syncrosome has acquired specific knowledge in PAH having tested a lot of compounds and having validating in house its models by several reference compounds.
During this congress we will present a poster on PAH.
"Pulmonary arterial hypertension (PAH) is a severe human disease with a markedly dec...
Syncrosome is a Preclinical Drug Evaluation Company specialised in human and animal health in vivo pharmacological studies. Syncrosome has the professional expertise to complete studies independently or to work in parallel with in-house research teams, after preliminary in vitro screenings - www.syncrosome.com